Ana Quesada

Prof. Ana Quesada

orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2004 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
AQAna Quesada
Ana Quesada
RMRamon Munoz-Chapuli
Ramon Munoz-Chapuli
Miguel Ángel MedinaMiguel Ángel Medina
Miguel Ángel Medina

1 September 1996 in British Journal of Cancer
Verified
Journal Article
Open access
PDF file
AQAna Quesada
Ana Quesada
GGGarcía Grávalos
García Grávalos
JPJl Fernández Puentes
Jl Fernández Puentes
The effects of several members of the family of lamellarins, polyaromatic alkaloids isolated from tunicates belonging to the genus Didemnum, on the growth of several tumour cell lines and on P-glycoprotein (P-gp)-mediated multidrug resistance (MDR), were investigated. Cytotoxicity experiments of lamellarins were performed on a panel of tumour cell lines, including two multidrug-resistant cell lines. Some lamellarins showed good anti-tumour activity, with similar levels of cytotoxicity against both the resistant and their corresponding parental cell lines. Two lamellarins displayed a high potency against lung carcinoma cells. Studies of the resistance modifier activity of the different lamellarins at non-toxic concentrations were also carried out in cells exhibiting MDR, and lamellarin I was selected for the highest chemosensitising activity. At non-toxic doses, verapamil and lamellarin I effectively increased the cytotoxicity of doxorubicin, vinblastine and daunorubicin in a concentration-dependent manner in multidrug-resistant cells, but the potency of lamellarin I as a MDR modulator was 9- to 16-fold higher than that of verapamil. In vitro measurements of rhodamine 123 accumulation in the multidrug-resistant Lo Vo/Dx cells suggest that lamellarin I reverses MDR by directly inhibiting the P-gp-mediated drug efflux. This work underscores the possibility of using these marine-derived compounds as a potential new source of anti-tumoral drugs active on resistant cells as well as of non-toxic modulators of the MDR phenotype.

1 July 1992 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
Miguel Ángel MedinaMiguel Ángel Medina
Miguel Ángel Medina
FSFrancisca Sánchez-Jiménez
Francisca Sánchez-Jiménez
JAVIER MARQUEZJAVIER MARQUEZ
JAVIER MARQUEZ
AQAna Quesada
Ana Quesada
INIgnacio de Castro Núñez
Ignacio de Castro Núñez

1 October 1986 in Canadian Journal of Microbiology
Verified
Journal Article
Closed access
AGAntonio Galvez
Antonio Galvez
MMMercedes Maqueda
Mercedes Maqueda
EVEva Valdivia
Eva Valdivia
AQAna Quesada
Ana Quesada
EME. Montoya
E. Montoya
Streptococcus faecalis S-48 produces a broad spectrum antibiotic, active against Gram-positive and Gram-negative bacteria. This substance is produced in solid and liquid media and also in a defined basal medium. It is sensitive to protease, pronase, or trypsin, heating at 70 °C, and alkaline pH, but resistant to treatment with lipase, lysozyme, alkaline phosphatase, DNAase, RNAase, acidic or neutral pHs, and also lower temperatures (60 °C). Several organic solvents cause precipitation, but not inactivation. This antibiotic has been partially purified by gel filtration and further ion-exchange chromatography. Its molecular weight has been estimated close to 2000. The biological activity of this antagonistic substance against the selected indicator strains, Streptococcus faecalis S-47 and Escherichia coli U-9, is bactericidal. The characterization of this substance, initially classified as a bacteriocin, indicates that it is an antibiotic of peptidic nature. The significance of antibiotic occurrence in group D of the genus Streptococcus is also discussed.

1 June 2006 in Life Sciences
Verified
Journal Article
Closed access
Miguel Ángel MedinaMiguel Ángel Medina
Miguel Ángel Medina
BMBeatriz Martínez-Poveda
Beatriz Martínez-Poveda
MAMaría I. Amores-Sánchez
María I. Amores-Sánchez
AQAna Quesada
Ana Quesada

1 May 2006 in Medicinal Research Reviews
Verified
Journal Article
Closed access
PDF file
AQAna Quesada
Ana Quesada
RMRamon Munoz-Chapuli
Ramon Munoz-Chapuli
Miguel Ángel MedinaMiguel Ángel Medina
Miguel Ángel Medina